SAFETY OF USTEKINUMAB ACROSS APPROVED ADULT INDICATIONS: POOLED SAFETY ANALYSIS IN CROHN’S DISEASE, ULCERATIVE COLITIS, PSORIASIS, AND PSORIATIC ARTHRITIS THROUGH UP TO 5 YEARS

Silvio Danese  ¹     Millie Long  ²     Elyssa Ott  ³     Christopher Gasink     Ye Miao  ⁴     Thomas Baker     Ilia Tikhonov     Proton Rahman  ⁵     Bruce Strober  ⁶     Edward V. Loftus  ^7    
1 Humanitas Research Hospital, Milan, Italy
² University of North Carolina at Chapel Hill, Chapel Hill, United States
³ Janssen Scientific Affairs, LLC, Horsham, United States
⁴ Janssen Research & Development, LLC, Spring House, United States
⁵ Memorial University of Newfoundland, St. John's, Canada
⁶ Yale University, New Haven, United States
⁷ Mayo Clinic, Rochester, United States

Topic
IBD

Session
Safety and outcomes of interventions in IBD

Conference
UEG Week Virtual 2021

Citation
United European Gastroenterology Journal 2021; 9 (Supplement 8)